Clinical trials
Phase 2 Hematologic Diseases trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Active, not recruiting | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Cogent Biosciences, Inc. | 2 |
| Boston University | 1 |
| Celgene | 1 |
| Cellectar Biosciences, Inc. | 1 |
| Copenhagen University Hospital at Herlev | 1 |
| Forma Therapeutics, Inc. | 1 |
| Seagen Inc. | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hematologic Diseases | 12 |
| Leukemia | 4 |
| Neoplasms | 4 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 |
| Leukemia, Myeloid | 3 |
| Myeloproliferative Disorders | 3 |
| Bone Marrow Diseases | 2 |
| Genetic Diseases, Inborn | 2 |
| Hematologic Neoplasms | 2 |
| Hypersensitivity | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.